comparemela.com

Latest Breaking News On - Agendia inc - Page 9 : comparemela.com

Agendia, Inc : Agendia Appoints Elizabeth Hanna as Executive Vice President and Chief Commercial Officer, Bolsters Company s Global Market Growth Strategy

Agendia, Inc., a commercial stage company focused on enabling optimized decision-making by providing physicians with next-generation diagnostic and information solutions that can be used to help improve

Mark straleyElizabeth betsy hannaTerri clevengerUniversity of illinoisHarvard business schoolAgendia incOrigin incTreace medical concepts incExecutive vice presidentChief commercial officerChief executive officerClinical genomicsChief operating officerJohnson vision careOrtho clinicalTreace medical concepts

Agendia, Inc : Agendia to Provide First Digital MammaPrint Capability to Brazil

AI solution will expand Agendia's testing platform in the Brazilian breast cancer market Digital MammaPrint offers fast turnaround time to molecular diagnostics, delivering actionable information

Mike cavanaughWilliam audehMark straleyAgendia mammaprintTerri clevengerDavid klimstraAgendia incDigital mammaprintChief executive officerPaige platformChief medical officerCancer mortalityYoung womenAgendia investors

Agendia, Inc : Agendia Appoints Suja Chandrasekaran and Scott Mendel to Board of Directors, Strengthening Advisory Group to Support Company Momentum

Agendia, Inc., a commercial stage company focused on precision oncology for breast cancer, today announced the appointment of healthcare industry veterans Suja Chandrasekaran, MS and Scott Mendel,

South australiaUnited statesTamil naduSuja chandrasekaranKostenloser wertpapierhandelMark straleyPatrickj balthropScott mendelAkoya biosciencesTerri clevengerIndiana universityNorthwestern university kellogg school of managementCommonspirit healthMaster of business systems at monash universityCompany board of directorsCompensation committee

Agendia, Inc : Agendia Spotlight Poster at SABCS 2021 Confirms Utility of BluePrint as Biomarker Subtyping Test to Guide Neoadjuvant Chemotherapy Decisions

Additional research from the real-world FLEX Registry focuses on age effect and lymph node status for patients with breast cancer Agendia, Inc., a world leader in precision oncology for breast

William audehCynthiax maTerri clevengerAgendia incNetherlands cancer instituteWashington university school of medicineAntonio breast cancer symposiumNetherlands cancerChief medical officerWashington university schoolLow risk

Agendia, Inc : Analysis Presented at SABCS 2021 Confirms MammaPrint and BluePrint Predict Outcomes Following Neoadjuvant Chemotherapy

Data signal importance of serial genomic testing in order to appropriately adjust breast cancer treatment plans Agendia, Inc., a world leader in precision oncology for breast cancer, today shared

William audehAlicep chungTerri clevengerAgendia incSinai medical centerDepartment of surgeryDivision of surgical oncologyAntonio breast cancer symposiumCedars sinai medicalMammaprint high riskMammaprint low riskHigh riskSurgical oncologyLow riskChief medical officerMammaprint risk

vimarsana © 2020. All Rights Reserved.